Table 2.
Clinical remission, mucosal healing, and quality of life scores according to infliximab levels.
| Disease control | TL ≥ 3 μg/mL | TL < 3 μg/mL | p value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Clinical remission | 24 | 85.7 | 12 | 27.9 | <0.001 |
| Mucosal healing | 24 | 85.7 | 8 | 18.6 | <0.001 |
|
| |||||
| Quality-of-life score | Mean | ±SD | Mean | ±SD | |
|
| |||||
| Bowel symptoms (maximum = 70) | 59.6 | 9.3 | 52.3 | 8.5 | 0.001 |
| Systemic function (maximum = 35) | 27.3 | 5.6 | 22.7 | 5.2 | 0.001 |
| Social function (maximum = 35) | 30.8 | 5.7 | 26.7 | 7.4 | 0.015 |
| Emotional status (maximum = 84) | 65.1 | 16.5 | 60.0 | 12.9 | 0.148 |
| Global (maximum = 224) | 183.0 | 32.6 | 161.9 | 28.9 | 0.006 |